Skip to main content

Table 2 Characteristics of patients

From: Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers

Characteristics

Non-ER (n = 16)

ER (n = 31)

P value

Age (years), Mean ± SD

57.69 ± 10.35

56.94 ± 8.83

0.795

Gender, No. (%)

  

0.763

 Male

7 (43.8)

15 (48.4)

 

 Female

9 (56.2)

16 (51.6)

 

Hepatitis, No. (%)

  

0.074

 Present

3 (18.8)

14 (45.2)

 

 Absent

13 (81.2)

17 (54.8)

 

CA199 level (U/ml), No. (%)

  

0.528

  < 37

6 (37.5)

9 (29.0)

 

  ≥ 37

6 (37.5)

18 (58.1)

 

 Not available

4 (25.0)

4 (12.9)

 

CEA level (ng/ml), No. (%)

  

0.851

  < 5

13 (81.3)

23 (74.2)

 

  ≥ 5

2 (12.5)

6 (19.4)

 

 Not available

1 (6.2)

2 (6.4)

 

Satellite lesions, No. (%)

  

0.316

 Absent

15 (93.8)

24 (77.4)

 

 Present

1 (0.2)

7 (22.6)

 

MTD, No. (%)

  

0.905

  < 5

7 (43.8)

13 (41.9)

 

  ≥ 5

9 (56.2)

18 (58.1)

 

Lesion location, No. (%)

  

0.780

 Left lobe

9 (56.2)

18 (58.1)

 

 Right lobe

7 (43.8)

11 (35.5)

 

 Left and Right lobe

0 (0)

2 (6.4)

 

Histologic grade, No. (%)

  

0.571

 Well

1 (6.2)

0 (0)

 

 Moderate

9 (56.2)

17 (54.8)

 

 Poor

6 (37.5)

14 (45.2)

 

T stage, No. (%)

  

0.074

 I/II

13 (81.2)

17 (54.8)

 

 III/IV

3 (18.8)

14 (45.2)

 

Lymph node metastasis, No. (%)

  

0.103

 Present

1 (6.2)

10 (32.3)

 

 Absent

15 (93.8)

21 (67.7)

 
  1. Note: ER early recurrence, CA199 carbohydrate antigen 199, CEA carcinoembryonic antigen, MTD maximum tumor diameter, *, P < 0.05